Mounjaro In Stock UK - All Doses Available | Cured

Clinically Proven UK Registered Pharmacy

Mounjaro In Stock - Cheapest UK Price From £124.99

Get the cheapest UK price on Mounjaro from £124.99 with £20 off your first order using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off first order using code WEIGHTLOSSNEW
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£145.00 From £124.99 £10 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation

Mounjaro In Stock UK - All Doses Available Now

Searching for Mounjaro in stock UK all doses? Cured Pharmacy currently holds full availability across all Mounjaro dose strengths, from starter 2.5mg pens through to maintenance 15mg doses. Our UK-registered clinical team can assess your suitability and arrange discreet delivery, typically within 24 hours of prescriber approval.

Current Mounjaro Stock Status at Cured Pharmacy

As of today, Cured Pharmacy maintains confirmed stock of all Mounjaro (tirzepatide) KwikPen doses: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. Unlike the widespread shortages affecting many UK pharmacies throughout 2024, our direct supply agreements with licensed wholesalers ensure consistent availability for patients requiring ongoing treatment.

Each Mounjaro pen is UK-licensed, MHRA-approved, and dispensed only after clinical assessment by our registered prescribers. Pricing starts from £124.99, with transparent costs displayed before you begin your free online consultation — no hidden fees or surprise charges at checkout.

Stock levels are monitored in real-time, and our pharmacy team proactively manages reordering to prevent treatment interruptions. If you've experienced delays or cancellations elsewhere, our superintendent pharmacist Tarun Kumar (GPhC 2233073) has implemented systems specifically designed to maintain continuity of care for weight management patients.

How Mounjaro Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed for weight management in the UK [1]. This dual-action mechanism sets it apart from single-pathway treatments: tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing enhanced effects on appetite regulation, gastric emptying, and insulin sensitivity.

In the landmark SURPASS-3 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — substantially higher than comparator treatments [1]. The SURMOUNT-1 trial, which focused specifically on weight management rather than diabetes control, demonstrated that 91% of participants achieved at least 5% weight loss, with 57% reaching 20% or greater reduction [2].

Clinical effects typically emerge within the first four weeks of treatment. Patients commonly report reduced hunger, earlier satiety during meals, and decreased food cravings. These effects are mediated by the medication's action on appetite-regulating centres in the hypothalamus, not through stimulant mechanisms or metabolic acceleration.

Dosing Schedule and Titration

Treatment begins with a 2.5mg weekly injection for four weeks, allowing your body to adjust to the medication and minimising gastrointestinal side effects. Your prescriber will then increase the dose in 2.5mg increments every four weeks, typically progressing through 5mg, 7.5mg, 10mg, and 12.5mg before reaching the maximum 15mg maintenance dose.

This gradual titration schedule, recommended by the MHRA and supported by clinical trial protocols, significantly reduces the incidence of nausea and vomiting compared to rapid dose escalation [3]. Your UK prescriber may adjust this schedule based on your individual response and tolerability.

Mounjaro vs Wegovy: Understanding Your Options

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are injectable medications licensed in the UK for weight management, but they differ in mechanism, efficacy data, and dosing. Wegovy activates only GLP-1 receptors, whilst Mounjaro's dual GIP/GLP-1 action produces different metabolic effects.

Head-to-head comparison data from the SURPASS-2 trial showed tirzepatide produced superior weight loss compared to semaglutide 1mg (used for diabetes management), with the 15mg tirzepatide dose achieving 5.5kg greater reduction on average [4]. Whilst direct comparison with Wegovy's 2.4mg dose hasn't been published in controlled trials, indirect comparisons suggest tirzepatide may offer enhanced efficacy for some patients.

Wegovy's advantage lies in its earlier market entry and slightly lower starting price point. Some patients also report better gastrointestinal tolerability with semaglutide, though individual responses vary considerably. Your prescriber will consider your medical history, previous treatment responses, and clinical goals when recommending between these options.

Alternative Weight Loss Treatments Available

Beyond injectable GLP-1 medications, Cured Pharmacy offers several evidence-based alternatives. Saxenda (liraglutide) requires daily rather than weekly injection but has extensive safety data from over a decade of clinical use. For patients preferring oral medication, Wegovy oral tablets provide semaglutide in pill form, though absorption requires specific timing around meals.

Orlistat-based treatments (including branded Xenical and Alli) work through a completely different mechanism — blocking dietary fat absorption rather than affecting appetite hormones. These may suit patients with contraindications to GLP-1 medications or those preferring non-injection options, though average weight loss is typically more modest.

Treatment Active Ingredient Administration Frequency Starting Price
Mounjaro Tirzepatide Subcutaneous injection Once weekly From £124.99
Wegovy Injection Semaglutide Subcutaneous injection Once weekly From £69.00
Saxenda Liraglutide Subcutaneous injection Once daily From £68.00
Wegovy Oral Tablets Semaglutide Oral tablet Once daily From £69.00
Orlistat Orlistat Oral capsule Three times daily From £32.00
Xenical Orlistat Oral capsule Three times daily From £32.00

Pricing and How to Order Mounjaro

Mounjaro pricing at Cured Pharmacy starts from £124.99 per four-week supply, with the exact cost determined by your prescribed dose strength. We display transparent pricing before you begin your consultation — no registration required to view costs, and no surprise fees during checkout.

The ordering process begins with a free online consultation taking under three minutes to complete. You'll answer questions about your medical history, current medications, weight management goals, and any previous experience with GLP-1 treatments. A UK-registered prescriber reviews your assessment, typically within hours during working days, and either approves your prescription or requests additional information.

Once approved, our pharmacy team dispenses your medication in discreet packaging with no external markings indicating contents. Most orders are dispatched the same working day for next-day delivery via tracked courier. You'll receive injection technique guidance, storage instructions, and direct access to our pharmacist team for any questions during your treatment.

Prescription Requirements and Eligibility

Mounjaro is a prescription-only medication in the UK, meaning it cannot legally be supplied without clinical assessment by a registered prescriber. NICE guidance recommends GLP-1 receptor agonists for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related health conditions such as type 2 diabetes, hypertension, or obstructive sleep apnoea.

Your prescriber will also screen for contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or pregnancy. Previous pancreatitis, gallbladder disease, and certain mental health conditions require careful assessment before treatment initiation.

Managing Side Effects and Treatment Expectations

Gastrointestinal side effects — particularly nausea, diarrhoea, constipation, and abdominal discomfort — are the most commonly reported reactions to Mounjaro, affecting up to 30% of patients during dose escalation [1]. These effects typically diminish within 4-8 weeks as your body adjusts, and the gradual titration schedule significantly reduces their severity.

Practical strategies can minimise these effects: eating smaller, more frequent meals rather than large portions; avoiding high-fat and heavily spiced foods during the first weeks; staying well-hydrated; and timing your injection for evenings if nausea tends to peak several hours post-dose. Your pharmacist can provide personalised advice based on your specific symptoms.

More serious but rare side effects include pancreatitis (severe abdominal pain radiating to the back), gallbladder problems, and hypoglycaemia if combined with certain diabetes medications. Seek immediate medical attention if you experience severe persistent abdominal pain, jaundice, or signs of an allergic reaction. Regular monitoring appointments with your prescriber ensure any concerns are identified and managed promptly.

Long-Term Weight Management and Treatment Duration

Clinical trials assessed Mounjaro for up to 72 weeks, demonstrating sustained weight loss throughout this period without plateau effects seen with some older treatments [2]. Real-world evidence suggests many patients maintain treatment for 12-24 months or longer, particularly when combined with lifestyle modifications including dietary changes and increased physical activity.

Weight regain after discontinuation is common, with studies showing patients typically regain approximately two-thirds of lost weight within one year of stopping GLP-1 medications [5]. This reflects the underlying biology of obesity as a chronic condition requiring ongoing management, not a short-term intervention. Your prescriber will discuss realistic expectations and long-term treatment plans during your consultation.

The decision to continue or discontinue treatment should be made collaboratively with your healthcare team, considering factors including weight loss achieved, improvement in weight-related health conditions, side effect tolerability, and personal treatment goals. Some patients transition to maintenance doses or alternative medications, whilst others incorporate planned treatment breaks with close monitoring.

Combining Medication with Lifestyle Changes

Mounjaro is most effective when used as part of a comprehensive weight management programme including dietary modification and increased physical activity. The medication facilitates these changes by reducing hunger and food preoccupation, making it easier to adhere to reduced-calorie eating patterns and establish new habits.

NHS guidance recommends aiming for a 500-600 calorie daily deficit through a combination of reduced intake and increased activity. Your prescriber may suggest referral to specialist weight management services, registered dietitians, or structured programmes that provide additional support alongside medication treatment.

Scientific References

  1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
  2. Garvey, W. T., et al. (2022). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet, 402(10402), 613–626. https://doi.org/10.1016/S0140-6736(23)01200-X
  3. Dahl, D., et al. (2022). Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA, 327(6), 534–545. https://doi.org/10.1001/jama.2022.0078
  4. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
  5. Wilding, J. P. H., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Mounjaro is a prescription-only medication that may not be suitable for everyone. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment and lifestyle modifications.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Is Mounjaro in stock at UK pharmacies right now?
Cured Pharmacy currently holds stock of all Mounjaro dose strengths (2.5mg through 15mg). Whilst some UK pharmacies have experienced supply interruptions, our direct wholesaler relationships maintain consistent availability for ongoing patient treatment.
How much does Mounjaro cost in the UK?
Mounjaro starts from £124.99 per four-week supply at Cured Pharmacy, with final pricing dependent on your prescribed dose strength. All costs are displayed transparently before you complete your free clinical consultation.
Can I buy Mounjaro without a prescription in the UK?
No. Mounjaro is a prescription-only medication under UK law and requires clinical assessment by a registered prescriber before it can legally be supplied. Websites offering Mounjaro without prescription are operating illegally and may supply counterfeit or unsafe products.
Which Mounjaro dose will I be prescribed?
All patients begin with 2.5mg weekly for four weeks, then titrate upwards in 2.5mg increments every four weeks based on response and tolerability. Your prescriber determines the optimal maintenance dose during ongoing reviews, typically ranging from 10mg to 15mg weekly.
How quickly does Mounjaro work for weight loss?
Most patients notice reduced appetite within 1-2 weeks of starting treatment, with measurable weight loss typically evident by week 4. Maximum effects emerge after reaching your maintenance dose, usually 20-24 weeks into treatment following the recommended titration schedule.
Is Mounjaro better than Wegovy for weight loss?
Clinical trial data suggests Mounjaro (tirzepatide) produces greater average weight loss than semaglutide-based treatments, with the SURPASS trials showing up to 22.5% body weight reduction. However, individual responses vary, and your prescriber will recommend the most suitable option based on your medical history and treatment goals.
What are the most common Mounjaro side effects?
Nausea, diarrhoea, constipation, and reduced appetite are the most frequently reported side effects, particularly during dose escalation. These effects are usually mild to moderate, temporary, and can be minimised through dietary adjustments and gradual dose titration.
How long will my Mounjaro prescription last?
Each Mounjaro pen contains four weekly doses (one month's supply). Your prescriber will typically issue 1-3 months of treatment initially, with ongoing prescriptions subject to regular review appointments to assess efficacy, tolerability, and continued appropriateness of treatment.
Are all Mounjaro doses in stock in the UK right now?
Yes, Cured Pharmacy currently has all Mounjaro doses in stock, from 2.5mg through to 15mg. Stock levels are updated daily, and orders are typically dispatched the same or next working day for fast delivery across the UK.
How do I get the cheapest Mounjaro price in the UK?
The cheapest way to buy Mounjaro in the UK is through Cured Pharmacy, starting at £124.99 for the 2.5mg dose. You can save an additional £20 off your first order by using the discount code Weightlossnew at checkout.
Does Mounjaro price change with each dose increase?
Yes, Mounjaro pricing increases with higher doses. At Cured Pharmacy, prices start at £124.99 for 2.5mg and go up to £267.00 for 15mg, reflecting the increased medication strength required as you progress through the treatment plan.
Is Mounjaro available on the NHS or only privately?
Mounjaro is currently only available privately in the UK for weight loss, not through the NHS. Cured Pharmacy offers Mounjaro with a UK-registered prescriber consultation and competitive pricing starting from £124.99 per pen.
Can I use my Mounjaro discount code on all doses?
Yes, the Weightlossnew discount code giving you £20 off applies to all Mounjaro doses at Cured Pharmacy. This code is valid for first-time customers and can be used regardless of which strength you are prescribed.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 17 July 2026